Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ceftobiprole Medocaril Sodium for Injection

Approval Number

国药准字H20253861

Company深圳华润九新药业有限公司

Registration Date

April 8, 2025

Drug Information

Generic Name

注射用头孢比罗酯钠

Dosage Form

注射剂

Strength

500mg（按C₂₀H₂₂N₈O₆S₂计）

Drug Type

化学药品

Registration Date

April 8, 2025

Company Information

Applicant Company

Company Name深圳华润九新药业有限公司

Company Address

深圳市福田区上梅林工业区凯丰路2号

Manufacturing Company

Company Name海南海灵化学制药有限公司

Company Address

海口市南海大道281号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy